Antibiotic-induced Porphyromonas gingivalis LPS release and inhibition of LPS-stimulated cytokines by antimicrobial peptides

Peptides

Volumn 31, Issue 9, 2010, Pages 1649-1653

  Walters, S M ^a   Dubey, V S ^a   Jeffrey, N R ^a   Dixon, D R ^a,b  

^a Great Lakes Naval Training Center   (United States)

^b EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

Antibiotics; Cytokines; Inflammation; Lipopolysaccharide; Porphyromonas gingivalis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CEFTAZIDIME; CYTOKINE; IMIPENEM; INTERLEUKIN 1BETA; INTERLEUKIN 6; METRONIDAZOLE; POLYPEPTIDE ANTIBIOTIC AGENT; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EXPOSURE; HUMAN; HUMAN TISSUE; INFLAMMATION; LIMULUS LYSATE TEST; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTEROIDACEAE INFECTIONS; BLOOD CELLS; CATHELICIDINS; CYTOKINES; HISTATINS; HUMANS; LIMULUS TEST; LIPOPOLYSACCHARIDES; OLIGOPEPTIDES; OSMOLAR CONCENTRATION; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN SYNTHESIS INHIBITORS; TIME FACTORS;

BACTERIA (MICROORGANISMS); LIMULUS; PORPHYROMONAS GINGIVALIS;

EID: 77955660231     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.06.001     Document Type: Article

References (35)

1. M.N. Al-Qutub, P.H. Braham, L.M. Karimi-Naser, X. Liu, C.A. Genco, and R.P. Darveau Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide Infect Immun 74 2006 4474 4485
2. M.T. Andres, W.O. Chung, M.C. Roberts, and J.F. Fierro Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain Antimicrob Agents Chemother 42 1998 3022 3023
3. P. Bidault, F. Chandad, and D. Grenier Systemic antibiotic therapy in the treatment of periodontitis J Can Dent Assoc 73 2007 515 520
4. J. Buijs, A.S. Dofferhoff, J.W. Mouton, and J.W. van der Meer Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis J Antimicrob Chemother 59 2007 926 933
5. N.P. Chongsiriwatana, J.A. Patch, A.M. Czyzewski, M.T. Dohm, A. Ivankin, and D. Gidalevitz Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc Natl Acad Sci USA 105 2008 2794 2799
6. R.P. Darveau, and R.E. Hancock Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains J Bacteriol 155 1983 831 838
7. R.P. Darveau, M.D. Cunningham, T. Bailey, C. Seachord, K. Ratcliffe, and B. Bainbridge Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion Infect Immun 63 1995 1311 1317
8. K. De Smet, and R. Contreras Human antimicrobial peptides: defensins, cathelicidins and histatins Biotechnol Lett 27 2005 1337 1347
9. D.R. Dixon, and R.P. Darveau Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure J Dent Res 84 2005 584 595
10. D.R. Dixon, L. Karimi-Naser, R.P. Darveau, and K.P. Leung The anti-endotoxic effects of the KSL-W decapeptide on Escherichia coli O55:B5 and various oral lipopolysaccharides J Periodontal Res 43 2008 422 430
11. D.R. Dixon, N.R. Jeffrey, V.S. Dubey, and K.P. Leung Antimicrobial peptide inhibition of Porphyromonas gingivalis 381-induced hemagglutination is improved with a synthetic decapeptide Peptides 30 2009 2161 2167
12. M.E. Evans, and M. Pollack Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli J Infect Dis 167 1993 1336 1343
13. E. Gemmell, R.I. Marshall, and G.J. Seymour Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease Periodontol 2000 14 1997 112 143
14. D.T. Graves, and D. Cochran The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction J Periodontol 74 2003 391 401
15. R.E. Hancock, and H.G. Sahl Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 24 2006 1551 1557
16. J.J. Jackson, and H. Kropp Differences in mode of action of beta-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy J Endotoxin Res 3 1996 201 218
17. J.J. Jackson, and H Kropp Antibiotic-induced endotoxin release: important parameters dictating responses Endotoxin in health and disease 1999 CRC Press p. 67-75
18. N. Kato, H. Kato, Y. Tanaka, K. Bando, K. Watanabe, and K. Ueno In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria Antimicrob Agents Chemother 37 1993 957 961 (Pubitemid 23141303)
19. D.F. Kinane, and D.F. Lappin Clinical, pathological and immunological aspects of periodontal disease Acta Odontol Scand 59 2001 154 160
20. P.M. Lepper, T.K. Held, E.M. Schneider, E. Bolke, H. Gerlach, and M. Trautmann Clinical implications of antibiotic-induced endotoxin release in septic shock Intensive Care Med 28 2002 824 833
21. S. Maher, and S. McClean Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro Biochem Pharmacol 71 2006 1289 1298
22. C.L. Manthey, and S.N. Vogel Elimination of trace endotoxin protein from rough chemotype LPS J Endotoxin Res 1 1994 84 91
23. N. Mookherjee, and R.E. Hancock Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections Cell Mol Life Sci 64 2007 922 933
24. D.C. Morrison, and S.E. Bucklin Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis Scand J Infect Dis Suppl 101 1996 3 8
25. S.M. Opal The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis Int J Med Microbiol 297 2007 365 377
26. J.M. Prins, E.J. Kuijper, M.L. Mevissen, P. Speelman, and S.J. van Deventer Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum Infect Immun 63 1995 2236 2242
27. E.T. Rietschel, and H. Brade Bacterial endotoxins Sci Am 267 1992 54 61
28. Y. Rosenfeld, N. Papo, and Y. Shai Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action J Biol Chem 281 2006 1636 1643
29. S. Rotem, and A. Mor Antimicrobial peptide mimics for improved therapeutic properties Biochim Biophys Acta 1788 2009 1582 1592
30. A.J. Simpson, S.M. Opal, B.J. Angus, J.M. Prins, J.E. Palardy, and N.A. Parejo Differential antibiotic-induced endotoxin release in severe melioidosis J Infect Dis 181 2000 1014 1019
31. D.M. Smith, G.A. Lackides, and L.B. Epstein Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity Cancer Res 50 1990 3146 3153
32. C.M. Tsai, and C.E. Frasch A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels Anal Biochem 119 1982 115 119
33. J. Van Damme, G. Opdenakker, R.J. Simpson, M.R. Rubira, S. Cayphas, and A. Vink Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor J Exp Med 165 1987 914 919
34. P. van Langevelde, K.M. Kwappenberg, P.H. Groeneveld, H. Mattie, and J.T. van Dissel Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS Antimicrob Agents Chemother 42 1998 739 743
35. E.C. Yi, and M. Hackett Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria Analyst 125 2000 651 656